Levoxyl shortage 2026?

Why is Levoxyl facing a shortage in 2026?

As of [1] 2026, Levoxyl, a thyroid medication, is facing a shortage due to manufacturing issues affecting its primary supplier, [2] AbbVie. The company has notified regulatory agencies and healthcare providers about the shortage, attributing it to problems with the active ingredient synthesis process.

What does this mean for patients?

The shortage of Levoxyl may lead to delays in medication supplies, forcing patients to seek alternative thyroid medications. However, patients should note that switching to other medications may require adjustments to their dosages, which should be done under the guidance of their healthcare provider.

How does this shortage affect the broader market for thyroid medications?

The shortage of Levoxyl may cause an increase in demand for alternative thyroid medications, such as Synthroid (levothyroxine). [3] As a result, patients may see changes in the availability or prices of these medications as the market adapts to the shortage.

Will there be any biosimilar options available during the shortage?

While biosimilar versions of levothyroxine are available, they are not exact matches to Levoxyl. Biosimilars are approved substitutes that have similar biologic characteristics, but their exact molecular structure may differ. Patients should seek guidance from their healthcare provider before switching to a biosimilar medication.

When does the Levoxyl patent expire?

According to [4] DrugPatentWatch.com, the patent for Levoxyl (levothyroxine) expired in 2021. As a consequence, the availability of generic or biosimilar alternatives may increase as companies develop and market their versions of the medication.

Sources:

[1] AbbVie (2026) - Notification of Levoxyl shortage
[2] AbbVie - AbbVie is a global biopharmaceutical company committed to discovering, developing, and delivering innovative treatments that challenge the status quo
[3] FDA (2026) - Levothyroxine sodium (Synthroid)
[4] DrugPatentWatch.com - DrugPatentWatch.com is a free online database that provides information on pharmaceutical patents, approvals, and regulatory information